Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4001
National Bankshares
NKSH
$272M
| $350K | ﹤0.01% |
10,425
+1,006
| +11% | +$30.5K |
2022 Q3
13 quarters
|
|
|
REFI
4002
Chicago Atlantic Real Estate Finance
REFI
$258M
| $349K | ﹤0.01% |
28,486
+2,916
| +11% | +$37.2K |
2022 Q1
15 quarters
|
|
|
CEPO
4003
Cantor Equity Partners I
CEPO
$274M
| $349K | ﹤0.01% |
+33,533
| New | +$351K |
2025 Q4
0 quarters
|
|
|
BLFY
4004
DELISTED
Blue Foundry Bancorp
BLFY
| $348K | ﹤0.01% |
28,027
+1,549
| +6% | +$15.5K |
2022 Q1
15 quarters
|
|
4005
Tonix Pharmaceuticals
TNXP
$153M
| $347K | ﹤0.01% |
22,231
+9,765
| +78% | +$180K |
2025 Q2
2 quarters
|
|
|
SNWV
4006
SANUWAVE Health Inc
SNWV
$41.5M
| $346K | ﹤0.01% |
11,610
+1,306
| +13% | +$41.9K |
2025 Q2
2 quarters
|
|
4007
Palladyne AI
PDYN
$263M
| $346K | ﹤0.01% |
81,226
+47,300
| +139% | +$318K |
2022 Q1
15 quarters
|
|
4008
3D Systems Corp
DDD
$628M
| $346K | ﹤0.01% |
195,334
-163
| -0.1% | -$397 |
2013 Q2
50 quarters
|
|
4009
Stereotaxis
STXS
$118M
| $346K | ﹤0.01% |
150,246
+7,062
| +5% | +$18.8K |
2024 Q2
6 quarters
|
|
4010
Perion Network
PERI
$334M
| $345K | ﹤0.01% |
36,033
+25,483
| +242% | +$247K |
2022 Q1
15 quarters
|
|
|
TBCH
4011
Turtle Beach Corp
TBCH
$251M
| $344K | ﹤0.01% |
24,511
+3,393
| +16% | +$50.5K |
2020 Q2
22 quarters
|
|
|
TBRG
4012
DELISTED
TruBridge
TBRG
| $344K | ﹤0.01% |
15,570
+1,149
| +8% | +$24.1K |
2024 Q3
5 quarters
|
|
4013
Opendoor
OPEN
$2.37B
| $344K | ﹤0.01% |
58,940
+9,885
| +20% | +$70.8K |
2022 Q1
15 quarters
|
|
4014
Falcon's Beyond
FBYD
$415M
| $343K | ﹤0.01% |
+22,864
| New | +$316K |
2025 Q4
0 quarters
|
|
4015
Certara
CERT
$1.43B
| $342K | ﹤0.01% |
38,816
+8,712
| +29% | +$89.7K |
2022 Q1
15 quarters
|
|
4016
Foghorn Therapeutics
FHTX
$120M
| $341K | ﹤0.01% |
63,190
+4,704
| +8% | +$21.3K |
2022 Q1
15 quarters
|
|
4017
Hagerty
HGTY
$1.52B
| $340K | ﹤0.01% |
25,333
-4
| -0% | -$50 |
2023 Q1
11 quarters
|
|
4018
Nkarta
NKTX
$185M
| $340K | ﹤0.01% |
183,923
+39,776
| +28% | +$79.5K |
2022 Q1
15 quarters
|
|
4019
Perma-Fix Environmental Services
PESI
$330M
| $340K | ﹤0.01% |
26,981
+2,612
| +11% | +$33.3K |
2024 Q2
6 quarters
|
|
|
CHYM
4020
Chime Financial
CHYM
$10.3B
| $338K | ﹤0.01% |
+13,437
| New | +$285K |
2025 Q4
0 quarters
|
|
|
FSFG
4021
DELISTED
First Savings Financial Group
FSFG
| $338K | ﹤0.01% |
10,607
+831
| +9% | +$25.8K |
2020 Q2
22 quarters
|
|
4022
PUT
SentinelOne
S
$8.72B
| $338K | ﹤0.01% |
22,500
| – | – |
2025 Q1
3 quarters
|
|
|
USAS
4023
Americas Gold and Silver
USAS
$1.49B
| $337K | ﹤0.01% |
65,874
+53,714
| +442% | +$242K |
2025 Q3
1 quarter
|
|
4024
OptimizeRx
OPRX
$161M
| $336K | ﹤0.01% |
27,441
+4,317
| +19% | +$70.5K |
2019 Q1
27 quarters
|
|
4025
iShares Global Consumer Staples ETF
KXI
$1.1B
| $336K | ﹤0.01% |
5,200
| – | – |
2020 Q4
20 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.